###begin article-title 0
Expression and Function of Macrophage Migration Inhibitory Factor (MIF) in Melioidosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: WJW TC TR DlR SJP TvdP. Performed the experiments: WJW LMK GJWvdW FCGJS. Analyzed the data: WJW TC LMK GJWvdW SF SJP FCGJS TvdP. Contributed reagents/materials/analysis tools: WJW TC TR DlR SF SJP FCGJS TvdP. Wrote the paper: WJW TC SJP FCGJS TvdP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 195 220 195 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia pseudomallei</italic>
###xml 195 220 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Macrophage migration inhibitory factor (MIF) has emerged as a pivotal mediator of innate immunity and has been shown to be an important effector molecule in severe sepsis. Melioidosis, caused by Burkholderia pseudomallei, is an important cause of community-acquired sepsis in Southeast-Asia. We aimed to characterize the expression and function of MIF in melioidosis.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 127 142 127 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 441 456 441 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 718 733 718 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 807 822 807 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 127 142 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 190 196 <span type="species:ncbi:10090">murine</span>
###xml 256 264 <span type="species:ncbi:9606">Patients</span>
###xml 407 411 <span type="species:ncbi:10090">Mice</span>
###xml 441 456 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 718 733 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 807 822 <span type="species:ncbi:28450">B. pseudomallei</span>
MIF expression was determined in leukocytes and plasma from 34 melioidosis patients and 32 controls, and in mice infected with B. pseudomallei. MIF function was investigated in experimental murine melioidosis using anti-MIF antibodies and recombinant MIF. Patients demonstrated markedly increased MIF mRNA leukocyte and MIF plasma concentrations. Elevated MIF concentrations were associated with mortality. Mice inoculated intranasally with B. pseudomallei displayed a robust increase in pulmonary and systemic MIF expression. Anti-MIF treated mice showed lower bacterial loads in their lungs upon infection with a low inoculum. Conversely, mice treated with recombinant MIF displayed a modestly impaired clearance of B. pseudomallei. MIF exerted no direct effects on bacterial outgrowth or phagocytosis of B. pseudomallei.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 88 96 <span type="species:ncbi:9606">patients</span>
MIF concentrations are markedly elevated during clinical melioidosis and correlate with patients' outcomes. In experimental melioidosis MIF impaired antibacterial defense.
###end p 7
###begin title 8
Author Summary
###end title 8
###begin p 9
###xml 67 92 67 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia pseudomallei</italic>
###xml 94 109 94 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 306 321 306 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 67 92 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 94 109 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 306 321 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
Melioidosis is a severe tropical infection caused by the bacterium Burkholderia pseudomallei. B. pseudomallei is the major cause of community-acquired septicemia in northeast Thailand with a mortality rate in severe cases of around 40% Little is known, however, about the mechanisms of the host defense to B. pseudomallei infection. Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that has emerged as an important mediator of the host defense in severe bacterial infections. In this article, we studied the expression and function of MIF both in patients with melioidosis and in mice during experimental melioidosis. We found that MIF concentrations were elevated in patients with melioidosis. Furthermore, high MIF concentrations are associated with poor outcome in patients with melioidosis. Also, in mice with experimentally induced melioidosis, we observed an upregulation of MIF concentrations. Furthermore, mice with melioidosis that were treated with a MIF blocking treatment showed lower bacterial counts in their lungs during infection. In conclusion, MIF seems to impair host defense mechanisms during melioidosis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-David1">[1]</xref>
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra1">[4]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Ayoub1">[5]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Bernhagen1">[6]</xref>
###xml 371 374 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra1">[4]</xref>
###xml 375 378 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Baugh1">[7]</xref>
###xml 632 635 632 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra1">[4]</xref>
###xml 765 768 765 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger1">[8]</xref>
###xml 769 772 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger2">[9]</xref>
###xml 843 846 843 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger1">[8]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Bozza1">[10]</xref>
###xml 981 985 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Chuang1">[11]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Lehmann1">[14]</xref>
###xml 1096 1100 1096 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Sprong1">[15]</xref>
###xml 1199 1215 1199 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 1253 1257 1253 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 1392 1396 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-AlAbed1">[17]</xref>
###xml 1397 1401 1397 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Crichlow1">[18]</xref>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 924 932 <span type="species:ncbi:9606">patients</span>
###xml 1023 1031 <span type="species:ncbi:9606">patients</span>
###xml 1159 1163 <span type="species:ncbi:10090">mice</span>
###xml 1199 1215 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1363 1367 <span type="species:ncbi:10090">mice</span>
Macrophage migration inhibitory factor (MIF) was one of the first cytokines to be discovered almost half a century ago [1]-[4]. Since then MIF has emerged as a pivotal mediator of innate immunity in various inflammatory diseases such as rheumatoid arthritis and atherosclerosis [5],[6] and is considered to be an integral component of the host antimicrobial alarm system [4],[7]. MIF, a classical proinflammatory cytokine, is constitutively expressed by many tissues with environmental contact such as the lung and the gastrointestinal tract, and by numerous cell types, among others T- and B-lymphocytes, monocytes and macrophages [4]. MIF-deficient macrophages are hyporesponsive to lipopolysaccharide (LPS) due to a down-regulation of Toll-like receptor (TLR)-4 [8],[9]. In line, MIF knockout mice were resistant to LPS induced toxic shock [8]-[10]. Recently it was shown that blood concentrations of MIF are elevated in patients with sepsis and able to predict early mortality [11]-[14]. Similarly, MIF is increased in patients with meningococcal disease and highest in the presence of shock [15]. Excitingly, treatment with anti-MIF antibodies protected mice from lethal peritonitis induced by Escherichia coli or cecal ligation and puncture (CLP) [16]. Furthermore, ISO-1 and OXIM-11, new small molecule inhibitors of MIF, offered significant protection to mice from CLP-induced sepsis [17],[18]. These data identified MIF as a potential mediator of lethality following abdominal sepsis.
###end p 11
###begin p 12
###xml 68 93 68 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia pseudomallei</italic>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-White1">[19]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga1">[20]</xref>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-White1">[19]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Currie1">[21]</xref>
###xml 547 562 547 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 68 93 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
###xml 547 562 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 620 626 <span type="species:ncbi:10090">murine</span>
In Southeast-Asia and Northern-Australia the gram-negative bacillus Burkholderia pseudomallei is an important cause of community-acquired sepsis [19],[20]. More than half of these cases of melioidosis, as this severe infection is named, habitually presents with pneumonia, frequently associated with bacterial dissemination to distant sites [19]-[21]. In the present study we aimed to characterize the expression and function of MIF in melioidosis. For this we analysed MIF expression patterns in patients with melioidosis and in a mouse model of B. pseudomallei infection. MIF function was investigated in experimental murine melioidosis using anti-MIF antibodies and recombinant MIF.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Ethics statement
###end title 14
###begin p 15
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 335 341 <span type="species:ncbi:10090">murine</span>
The patient study was approved by both the Ministry of Public Health, Royal Government of Thailand and the Oxford Tropical Research Ethics Committee, University of Oxford, England. We obtained written informed consent from all subjects before the study. The Animal Care and Use of Committee of the University of Amsterdam approved all murine experiments.
###end p 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 16
###begin p 17
###xml 49 64 49 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 277 292 277 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Levy1">[22]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 49 64 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 277 292 <span type="species:ncbi:28450">B. pseudomallei</span>
We included 34 individuals with sepsis caused by B. pseudomallei and 32 healthy controls in this study. Individuals were recruited prospectively at Sapprasithiprasong Hospital, Ubon Ratchathani, Thailand in 2004. Sepsis due to melioidosis was defined as culture positivity for B. pseudomallei from any clinical sample plus a systemic inflammatory response syndrome (SIRS) [22]. Study design and subjects have been described in detail [23].
###end p 17
###begin title 18
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human plasma MIF and MIF mRNA measurements
###end title 18
###begin p 19
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Radstake1">[24]</xref>
###xml 412 416 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Spek1">[25]</xref>
###xml 417 421 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga3">[26]</xref>
###xml 597 601 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Spek1">[25]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human MIF was measured by ELISA, as described elsewhere [24]. In addition, MIF mRNA levels were measured as follows. Heparin blood samples were drawn from an antecubital vein and immediately put on ice. Leukocytes were isolated using erylysis buffer, dissolved in Trizol and stored at -80degreesC. Thereafter, RNA was isolated and analyzed by multiplex ligation-dependent probe amplification (MLPA) as described [25],[26] (MRC-Holland, Amsterdam, the Netherlands). Levels of mRNA were expressed as a normalized ratio of the peak area divided by the peak area of the beta2 microglobulin (B2M) gene [25].
###end p 19
###begin title 20
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine melioidosis
###end title 20
###begin p 21
###xml 176 191 176 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-DeShazer1">[27]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Jeddeloh1">[28]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga4">[29]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 370 371 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 379 380 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 390 391 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 556 560 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 561 565 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga5">[30]</xref>
###xml 566 570 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga7">[32]</xref>
###xml 649 653 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 655 659 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga4">[29]</xref>
###xml 660 664 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 908 912 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 913 917 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 918 922 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra3">[34]</xref>
###xml 999 1003 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 1004 1008 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra3">[34]</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 176 191 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 830 835 <span type="species:ncbi:10090">mouse</span>
###xml 924 930 <span type="species:ncbi:9986">Rabbit</span>
Male C57BL/6 mice (age 8-10 weeks) were purchased from Harlan Sprague Dawley Inc. (Horst, The Netherlands). Age-matched animals were used in each experiment. For the inoculum, B. pseudomallei strain 1026b, kindly provided by Dr. Don Woods [27],[28], was used and prepared as described [23], [29]-[31]. Pneumonia was induced by intranasal inoculation of a 50 microl (5x101, 2.5x102 or 7.5x102 colony forming units (CFU)/50 microl) bacterial suspension. 48 hours after infection, mice were anesthetized and sacrificed by bleeding from the vena cava inferior [23],[30],[32]. CFUs were determined from serial dilutions of organ homogenates as described [23], [29]-[31]. In some experiments mice were injected intraperitoneally with 2 mg of anti-MIF or non-immune IgG 2 hours before bacterial inoculation or with 50 microg recombinant mouse MIF or control buffer at the onset of infection as described previously [16],[33],[34]. Rabbit polyclonal anti-MIF and recombinant MIF were generated as described [16],[34].
###end p 21
###begin title 22
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine assays
###end title 22
###begin p 23
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Grebenchtchikov1">[35]</xref>
The ELISA for mMIF developed according to the 4-span approach was used as described in detail [35]. Tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-6, IL-10 and IL-12p70 were determined using a cytometric bead array (CBA) multiplex assay in accordance with the manufacturer's instructions (BD Biosciences, San Jose, CA).
###end p 23
###begin title 24
MIF immunochemistry and histologic examination
###end title 24
###begin p 25
###xml 1381 1385 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 445 449 <span type="species:ncbi:9925">goat</span>
###xml 549 555 <span type="species:ncbi:9986">rabbit</span>
###xml 613 619 <span type="species:ncbi:9913">bovine</span>
###xml 727 731 <span type="species:ncbi:9925">goat</span>
###xml 737 743 <span type="species:ncbi:9986">rabbit</span>
###xml 1058 1064 <span type="species:ncbi:9986">rabbit</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
Four-microm thick lung tissue sections were sampled 48 hours after infection and mounted on aminopropylmethoxysilane-coated glass slides, deparaffinized in xylol, taken through to absolute alcohol and blocked for endogenous peroxidase with 0.1% hydrogen peroxide in methanol. They were boiled in 10 mM citrate buffer in a microwave oven and rinsed in Tris-buffered saline (TBS). To reduce non-specific binding, sections were incubated in normal goat serum (Pel-Freez Biologicals, Rogers, AK) 1:30 in TBS. After 40-minutes incubation with polyclonal rabbit anti-MIF purified IgG diluted 1:200 in TBS containing 2% bovine serum albumin (final immunoglobulin concentration: 25 mg/l), the sections were incubated with biotinylated goat anti-rabbit IgG (Vector, Burlingame, CA) diluted 1:400 and then with ABC-peroxidase complex solution (Vector). Peroxidase activity was revealed with 5-5'-diaminobenzidine as chromogen and the sections were counterstained in Meyer's acid-free hematoxylin. As a negative control, the primary antibody was replaced by pre-immune rabbit purified IgG. Furthermore, to score inflammation, lung and livers from infected mice were harvested 48 hours after infection, fixed in 10%-formalin and embedded in paraffin. Four microm sections were stained with hematoxylin and eosin and analyzed by a pathologist blinded for groups exactly as described previously [23].
###end p 25
###begin title 26
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Effect of MIF on bacterial growth in vitro
###end title 26
###begin p 27
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 81 96 81 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 15 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 81 96 <span type="species:ncbi:28450">B. pseudomallei</span>
B. pseudomallei strain 1026b was used and prepared as described above. In short, B. pseudomallei at concentrations from 3x103-3x106 CFU/ml was grown in the presence of recombinant MIF (dose range from 5 to 50 microg/ml) diluted in LB-growth medium.
###end p 27
###begin title 28
Phagocytosis
###end title 28
###begin p 29
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wan1">[36]</xref>
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga8">[37]</xref>
###xml 63 78 63 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 290 305 290 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 313 314 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 63 78 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 290 305 <span type="species:ncbi:28450">B. pseudomallei</span>
Phagocytosis was evaluated as described [36],[37]. Heat-killed B. pseudomallei was labeled with carboxyfluorescein-diacetate-succinimidyl-ester (CFSE dye, Invitrogen, Breda, The Netherlands). Peritoneal macrophages (derived from 5 different mice per group) were incubated with CFSE-labeled B. pseudomallei (2.5x107 CFU/ml) for 0, 60 and 120 minutes. Phagocytosis was stopped by placing cells on ice; thereafter cells were washed in PBS and suspended in Quenching solution (Orpegen, Heidelberg, Germany). To determine the neutrophil phagocytosis capacity, 50 microl of whole blood was incubated with bacteria after which cells were suspended in Quenching solution, incubated in FACS lysis/fix solution (BecktonDickinson) and neutrophils were labeled using anti-Gr-1-PE (Pharmingen). Phagocytosis was determined using FACS.
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
###xml 399 400 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Values are expressed as means +/- standard error of the mean (SEM). Differences between groups were analyzed by Mann-Whitney U test or Kruskal-Wallis analysis with Dunn's posthoc test where appropriate. For survival analysis, Kaplan-Meier analysis followed by log rank test was performed. These analyses were performed using GraphPad Prism version 4.00, GraphPad Software (San Diego, CA). Values of P<0.05 were considered statistically significant.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 30 38 <span type="species:ncbi:9606">patients</span>
MIF expression is elevated in patients with melioidosis and correlates with poor outcome
###end title 33
###begin p 34
###xml 130 145 130 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, P</italic>
###xml 412 424 412 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g001">Figure 1<italic>A, P</italic></xref>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, P</italic>
###xml 594 606 594 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g001">Figure 1<italic>B, P</italic></xref>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, P</italic>
###xml 752 764 752 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g001">Figure 1<italic>C, P</italic></xref>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 130 145 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
To obtain an insight into MIF expression during melioidosis, we first measured MIF in plasma from 34 patients with culture proven B. pseudomallei infection and in plasma from 32 local healthy controls. The mortality rate in this cohort of patients was 44%. MIF was markedly elevated in melioidosis patients with mean plasma concentrations that were approximately 2-fold higher than in those of healthy subjects (Figure 1A, P<0.01). Plasma concentrations of MIF were associated with an adverse outcome: on admission patients who went on to had higher MIF concentrations than those who survived (Figure 1B, P<0.01). In line, MIF mRNA levels were significantly higher in peripheral blood leukocytes from patients than in leukocytes from healthy controls (Figure 1C, P<0.001).
###end p 34
###begin title 35
###xml 65 73 <span type="species:ncbi:9606">patients</span>
MIF plasma and leukocyte mRNA levels are elevated in melioidosis patients and correlate with poor outcome.
###end title 35
###begin p 36
###xml 209 210 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 336 337 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 463 464 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">Patients</span>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
In patients (black triangle, n = 34) with melioidosis, strongly increased plasma concentrations of plasma MIF were present on admission when compared to healthy controls (blacksquare, square, filled, n = 32) (A). Patients who went on to die from melioidosis had higher MIF plasma concentrations on admission than patients who survived (B). MIF mRNA was strongly upregulated in the peripheral blood leukocytes of melioidosis patients compared to healthy controls (C). B2M: beta2 microglobulin. ** p<0.01; *** p<0.001.
###end p 36
###begin title 37
Increased MIF expression in the pulmonary compartment during experimental pneumonia-derived melioidosis
###end title 37
###begin p 38
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-White1">[19]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Currie1">[21]</xref>
###xml 369 384 369 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga4">[29]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 579 587 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g002">Figure 2</xref>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 879 880 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g003">Figure 3<italic>A</italic></xref>
###xml 949 964 949 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1137 1138 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1129 1138 1129 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g003">Figure 3<italic>B</italic></xref>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 278 284 <span type="species:ncbi:10090">murine</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 369 384 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 949 964 <span type="species:ncbi:28450">B. pseudomallei</span>
Since the majority of severe melioidosis cases presents with pneumonia with bacterial dissemination to distant body sites [19]-[21] and considering the fact that it is not feasible to study MIF expression at tissue level in patients with melioidosis, we used a well-established murine model of pneumonia-derived melioidosis in which mice are intranasally infected with B. pseudomallei[23],[29],[31]. In agreement with the data obtained in patients with melioidosis, infected mice showed an abundant upregulation of MIF expression, both in the pulmonary and systemic compartment (Figure 2, both P<0.01). Immunohistochemical staining of lung tissue was performed to further identify the distribution of MIF expression during melioidosis. Positive immunostaining for MIF was observed in untreated control animals in alveolar macrophages and within the bronchial epithelium (Figure 3A). Granulocytes did not stain positive for MIF. After infection with B. pseudomallei there was a marked increase in immunostaining of the epithelial submucosa, bronchial epithelial cells and inflammatory cells, most notably of alveolar macrophages (Figure 3B).
###end p 38
###begin title 39
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Increased MIF concentrations during experimental melioidosis in mice.
###end title 39
###begin p 40
###xml 91 106 91 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 91 106 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
Pulmonary MIF expression was strongly increased 72 hours after intranasal inoculation with B. pseudomallei (A). Plasma MIF concentrations remained constant during the first two days of infection, followed by a steep increase over time (B). Data are means +/- SEM of 5 mice per group at each time point. ** p<0.01 versus t = 0.
###end p 40
###begin title 41
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Immunostaining for MIF in the lungs of mice.
###end title 41
###begin p 42
###xml 148 149 148 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 182 197 182 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 362 363 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 182 197 <span type="species:ncbi:28450">B. pseudomallei</span>
Positive immunostaining for MIF in lung tissue was observed in non-infected control animals of bronchial epithelial cells and alveolar macrophages (A). 48 hours after infection with B. pseudomallei there was a marked increase in immunostaining of the epithelial submucosa, bronchial epithelial cells and inflammatory cells, most notably of alveolar macrophages (B). Magnification x10, insets x20.
###end p 42
###begin title 43
Effect of recombinant MIF treatment on bacterial outgrowth
###end title 43
###begin p 44
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 126 141 126 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 261 265 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 266 270 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 448 449 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 677 685 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g004">Figure 4</xref>
###xml 831 839 823 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g004">Figure 4</xref>
###xml 841 842 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1076 1084 1068 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g004">Figure 4</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 126 141 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">Mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
To obtain a first insight into the function of MIF during experimental melioidosis, we treated mice infected with 2.5x102 CFU B. pseudomallei mice with 50 microg recombinant MIF using a dose similar to that used previously in an experimental septic shock model [16],[33]. Treatment of mice with recombinant MIF at the time of infection resulted in increased MIF concentrations in lung homogenates 48 hours later (from 33+/-1.3 to 729+/-56.6 ng/ml; P<0.001). Mice were sacrificed 48 hours after inoculation to determine bacterial loads in lungs (the primary site of the infection), liver and blood (to evaluate to which extent the infection disseminated to distant body sites) (Figure 4). Relative to infected but non-treated controls, mice treated with recombinant MIF displayed almost 10-fold higher bacterial loads in the liver (Figure 4, P<0.01). In addition, a clear trend was seen towards higher bacterial loads in the pulmonary and systemic compartments of recombinant MIF treated mice, although the differences with control mice did not reach statistical significance (Figure 4).
###end p 44
###begin title 45
Effect of recombinant MIF on bacterial clearance.
###end title 45
###begin p 46
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 110 125 110 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 192 193 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 203 204 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 217 218 217 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 110 125 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
Mice, treated with control buffer (white bars) or recombinant MIF (grey bars) and inoculated with 2.5x102 CFU B. pseudomallei intranasally, were analysed for bacterial outgrowth in the lungs (A), liver (B) and blood (C) 48 hours later. Data represent mean +/- SEM of n = 8 mice per group; ** p<0.01.
###end p 46
###begin title 47
Effect of anti-MIF treatment on bacterial outgrowth
###end title 47
###begin p 48
###xml 385 400 385 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 728 729 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 734 749 734 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g005">Figure 5</xref>
###xml 1014 1015 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1020 1035 1020 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1052 1053 1052 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1058 1073 1058 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1085 1093 1085 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g006">Figure 6</xref>
###xml 1222 1223 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1214 1223 1214 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g006">Figure 6<italic>B</italic></xref>
###xml 1309 1324 1309 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1378 1382 1378 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, P</italic>
###xml 1370 1382 1370 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g006">Figure 6<italic>A, P</italic></xref>
###xml 1447 1459 1447 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 1546 1561 1546 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1809 1824 1809 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1988 1996 1988 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000605-g007">Figure 7</xref>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 385 400 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
###xml 519 526 <span type="species:ncbi:562">E. coli</span>
###xml 734 749 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1020 1035 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1058 1073 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
###xml 1309 1324 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1364 1368 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
###xml 1546 1561 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1681 1685 <span type="species:ncbi:10090">mice</span>
###xml 1809 1824 <span type="species:ncbi:28450">B. pseudomallei</span>
Having found that administration of supra physiological doses of MIF results in a partially impaired bacterial clearance during experimental melioidosis, we next hypothesized that treatment with anti-MIF antibodies would result in decreased bacterial outgrowth and performed the reverse experiment by examining the effect of anti-MIF treatment. Therefore, before inoculating mice with B. pseudomallei, we injected mice with anti-MIF antibodies using a dosing schedule previously found be protective in a mouse model of E. coli or CLP-induced peritonitis [16],[33]. To evaluate whether anti-MIF treatment interferes with bacterial clearance, we first determined bacterial loads 48 hours after infection with an inoculum of 2.5x102 CFU B. pseudomallei (Figure 5). At this dose no significant differences in bacterial outgrowth in either lungs, liver or blood were observed. To determine whether the effect of anti-MIF therapy is dependent on the size of the infectious dose, we next infected mice with a higher (5x102 CFU B. pseudomallei) and lower (5x101 CFU B. pseudomallei) inoculum (Figure 6). At the highest dose no effect of anti-MIF treatment was seen on the bacterial outgrowth in the lungs, liver or blood (Figure 6B). However, at the lowest inoculum mice treated with anti-MIF had almost 10-fold less B. pseudomallei CFU in their lungs compared to control mice (Figure 6A, P<0.05). With this low inoculum, none of the mice showed positive Burkholderia cultures in liver or blood, suggesting that anti-MIF treatment inhibits the growth of B. pseudomallei in the lungs after infection with a relatively low bacterial dose. Lastly, we performed a survival experiment in which mice were injected intraperitoneally with 2 mg of anti-MIF or non-immune control IgG 2 hours before intranasal inoculation with B. pseudomallei. In accordance with the modest protective effect of anti-MIF treatment on bacterial outgrowth a limited survival advantage was seen in the anti-MIF treated group (Figure 7).
###end p 48
###begin title 49
Effect of anti-MIF antibodies on bacterial clearance.
###end title 49
###begin p 50
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 126 141 126 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 201 202 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 212 213 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 126 141 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
Mice were treated with non-immune IgG control (white bars) or anti-MIF antibodies (grey bars) and inoculated with 2.5x102 CFU B. pseudomallei intranasally after which bacterial outgrowth in the lungs (A), liver (B) and blood (C) was analysed 48 hours later. Data represent mean +/- SEM of n = 8 mice per group.
###end p 50
###begin title 51
Effect of anti-MIF treatment on bacterial clearance is dependent on the inoculum size.
###end title 51
###begin p 52
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 125 126 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 145 160 145 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 377 392 377 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 145 160 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 377 392 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
Mice were treated with non-immune IgG control (white bars) or anti-MIF antibodies (grey bars) and inoculated with 5x101 CFU (A) or 5x102 CFU (B) B. pseudomallei intranasally after which bacterial outgrowth in the lungs, liver and blood was analysed 48 hours later. No bacterial outgrowth in the liver and no bacteremia was observed in any of the mice inoculated with 5x101 CFU B. pseudomallei. Data represent mean +/- SEM of n = 8 mice per group; * p<0.05.
###end p 52
###begin title 53
###xml 79 94 79 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 79 94 <span type="species:ncbi:28450">B. pseudomallei</span>
Effect of treatment with anti-MIF antibodies on survival of mice infected with B. pseudomallei.
###end title 53
###begin p 54
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 200 215 200 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 200 215 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
Mice were injected intraperitoneally with 2 mg of anti-MIF (straight line with downward arrow) or non-immune control IgG (dashed line with upward arrow) 2 hours before inoculation with 5.0x102 CFU of B. pseudomallei intranasally; n = 12 mice per group; * p<0.05.
###end p 54
###begin title 55
Influence of anti-MIF and recombinant MIF on the inflammatory response
###end title 55
###begin p 56
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Mizgerd1">[38]</xref>
###xml 247 254 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 262 266 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 267 271 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 419 420 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 425 440 413 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 442 449 430 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 442 449 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000605-t001"><bold>Table 1</bold></xref>
###xml 565 572 553 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 565 572 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000605-t001"><bold>Table 1</bold></xref>
###xml 710 714 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Bozza1">[10]</xref>
###xml 715 719 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 896 911 872 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1050 1057 1022 1029 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1050 1057 1022 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000605-t001"><bold>Table 1</bold></xref>
###xml 1468 1483 1440 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 247 254 <span type="species:ncbi:562">E. coli</span>
###xml 425 440 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 896 911 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
###xml 1404 1408 <span type="species:ncbi:10090">mice</span>
###xml 1468 1483 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1498 1502 <span type="species:ncbi:10090">mice</span>
Since cytokines are important regulators of the inflammatory response to acute lower respiratory tract infection [38] and given the observation that protective anti-MIF treatment reduced TNFalpha concentrations in mouse model of sepsis induced by E. coli or CLP [16],[33], we measured the concentrations of TNFalpha, IL-6, IL-10, IL-12 and IFNgamma in lung homogenates and plasma obtained 48 after infection with 2.5x102 CFU B. pseudomallei (Table 1). Anti-MIF treatment did not influence pulmonary cytokine concentrations in our model of experimental melioidosis (Table 1). Previously it was shown that plasma TNFalpha concentrations induced by LPS were lower in MIF-deficient mice compared to wild-type mice [10],[33]. However also in plasma no differences in TNFalpha or IL-6, IL-10, IL-12 and IFNgamma concentrations were seen between anti-MIF treated and control mice after inoculation with B. pseudomallei (data not shown). In addition treatment with 50 microg recombinant MIF did not influence cytokine concentrations in either the pulmonary (Table 1) or systemic compartment (data not shown). Considering that MIF is regarded as an important proinflammatory mediator, we determined whether modulation of MIF concentrations could have an effect on organ inflammation during experimental melioidosis. Therefore, we performed histopathological analyses of lung and liver tissues in control mice and mice treated with anti-MIF or recombinant MIF and infected with B. pseudomallei. Although all mice showed evidence of inflammation as characterized by diffuse infiltrates, interstitial inflammation and bronchitis there were no differences in total organ histopathological scores between groups (data not shown).
###end p 56
###begin title 57
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Cytokine concentrations (pg/ml) in lung homogenates of mice treated with anti-MIF antibodies or recombinant MIF during experimental melioidosis.
###end title 57
###begin p 58
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 78 93 78 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 78 93 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 95 99 <span type="species:ncbi:10090">Mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Pulmonary cytokine concentrations after intranasal infection with 2.5x102 CFU B. pseudomallei. Mice were sacrificed 48 hours after infection. Data are means +/- SEM of eight mice per group per time point. TNF-alpha: tumor-necrosis-factor (TNF)-alpha; IL  =  interleukin; IFN-gamma  =  Interferon-gamma.
###end p 58
###begin title 59
No direct effect of MIF on bacterial outgrowth or phagocytosis
###end title 59
###begin p 60
###xml 202 217 202 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 334 349 334 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 698 713 694 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 775 790 771 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 202 217 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 334 349 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 698 713 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 775 790 <span type="species:ncbi:28450">B. pseudomallei</span>
Having found that anti-MIF treated mice showed lower bacterial loads in their lungs upon infection with a low inoculum while mice treated with recombinant MIF displayed a modestly impaired clearance of B. pseudomallei, we next wished to determine whether MIF has a direct effect on bacterial outgrowth and/or phagocytosis. Therefore, B. pseudomallei (at concentrations from 3x103-3x106 CFU/ml) was grown in the presence of recombinant MIF diluted in the growth medium (dose range from 5 to 50 microg/ml). However, no effects of recombinant MIF on bacterial outgrowth could be observed at any time point (up to 2 hours; data not shown). Lastly, we studied whether MIF contributes to phagocytosis of B. pseudomallei. However no effects of anti-MIF treatment on phagocytosis of B. pseudomallei by peritoneal macrophages or whole blood neutrophils could be observed (data not shown).
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 515 530 515 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 795 810 795 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 969 984 969 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 1085 1101 1085 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei.</italic>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 515 530 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 795 810 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
###xml 969 984 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1085 1100 <span type="species:ncbi:28450">B. pseudomallei</span>
In the present study we aimed to characterize the expression and role for MIF in melioidosis, linking observational studies in patients with culture-proven disease with functional studies in mice in which we modulated the concentrations of MIF during experimentally induced melioidosis. Our study shows that patients with severe melioidosis have strongly increased MIF plasma and MIF mRNA leukocyte levels. High plasma MIF concentrations were associated with mortality. Similarly, mice intranasally inoculated with B. pseudomallei displayed a strong increase in pulmonary and systemic MIF expression. The functional role of MIF in our model of experimental melioidosis however was modest given the fact that modulation of MIF levels only moderately influenced the innate immune response towards B. pseudomallei. Anti-MIF treatment resulted in a modest survival benefit. Anti-MIF treatment only decreased bacterial outgrowth when mice were inoculated with a low dose of B. pseudomallei whereas - conversely - mice treated with recombinant MIF displayed a modestly impaired clearance of B. pseudomallei. These data are the first to report on the expression and function of MIF during melioidosis.
###end p 62
###begin p 63
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Chen1">[39]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Kibiki1">[41]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-McDevitt1">[42]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Yamada1">[43]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Chuang1">[11]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Emonts1">[12]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Sprong1">[15]</xref>
###xml 622 644 622 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitides</italic>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Emonts1">[12]</xref>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Awandare1">[44]</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Sprong1">[15]</xref>
###xml 1229 1233 1229 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Kibiki1">[41]</xref>
###xml 117 120 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 125 140 <span type="species:ncbi:11082">West Nile virus</span>
###xml 355 363 <span type="species:ncbi:9606">patients</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
###xml 856 864 <span type="species:ncbi:9606">children</span>
###xml 971 979 <span type="species:ncbi:9606">children</span>
###xml 1038 1043 <span type="species:ncbi:9606">human</span>
###xml 1136 1139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1153 1161 <span type="species:ncbi:9606">patients</span>
MIF expression is increased in a wide variety of infectious diseases, ranging from viral infections, such as Dengue, HIV and West Nile virus infection [39]-[41], malaria [42], tuberculosis [43] and various forms of sepsis [11],[12],[15]. Our study further extends these findings by demonstrating increased plasma and blood leukocyte mRNA levels of MIF in patients with severe melioidosis. Importantly, we demonstrated a strong association between elevated MIF levels and increased mortality. This is in line with a recent study among pediatric and adult patients with severe sepsis or septic shock caused predominantly by Neisseria meningitides and other gram-negative bacteria in which elevated MIF levels were shown to be predictive of early mortality [12]. MIF, however, is not always upregulated after acute infection or inflammation. For instance, in children with acute malaria circulating MIF levels were significantly lower compared with healthy, malaria-exposed children [44]. Furthermore, MIF release could not be detected in a human endotoxemia model and is not produced by whole blood cells incubated with LPS [15]. Also in HIV seropositive patients low serum MIF levels were associated with a high 1-month mortality [41]. This further highlights the potential diverse roles MIF can play in the host response against various invading pathogens.
###end p 63
###begin p 64
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-White1">[19]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga1">[20]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga1">[20]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Currie1">[21]</xref>
###xml 324 339 324 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga9">[45]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga3">[26]</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga4">[29]</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 1056 1063 1056 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1071 1074 1071 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra1">[4]</xref>
###xml 1075 1079 1075 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Makita1">[46]</xref>
###xml 1190 1206 1190 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei.</italic>
###xml 1554 1561 1554 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1569 1572 1569 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger2">[9]</xref>
###xml 1573 1577 1573 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 1907 1911 1903 1907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Yende1">[47]</xref>
###xml 2077 2081 2073 2077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Matsuda1">[48]</xref>
###xml 2156 2171 2152 2167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 2282 2285 2278 2281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger2">[9]</xref>
###xml 2286 2290 2282 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 2446 2449 2442 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger1">[8]</xref>
###xml 2593 2600 2589 2596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2673 2677 2669 2673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 2749 2764 2745 2760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 2901 2923 2897 2919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 3097 3101 3093 3097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Sashinami1">[49]</xref>
###xml 324 339 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 430 438 <span type="species:ncbi:9606">patients</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
###xml 912 917 <span type="species:ncbi:10090">mouse</span>
###xml 972 979 <span type="species:ncbi:9606">patient</span>
###xml 1016 1022 <span type="species:ncbi:10090">murine</span>
###xml 1056 1063 <span type="species:ncbi:562">E. coli</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1190 1205 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1554 1561 <span type="species:ncbi:562">E. coli</span>
###xml 1676 1680 <span type="species:ncbi:10090">mice</span>
###xml 2009 2017 <span type="species:ncbi:9606">patients</span>
###xml 2156 2171 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 2749 2764 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 2894 2900 <span type="species:ncbi:10090">murine</span>
###xml 2901 2923 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 3070 3074 <span type="species:ncbi:10090">mice</span>
Melioidosis, which is the most common form of community-acquired sepsis in Northern-Australia and Eastern-Thailand, is associated with a mortality of up to 50% in endemic areas [19],[20]. Severe pneumonia with bacterial dissemination to distant body sites is a common presentation of melioidosis [20],[21]. Sepsis caused by B. pseudomallei is characterized by a markedly proinflammatory cytokine profile; in the current cohort of patients we have demonstrated increased plasma concentrations of IL-6, IL-8 and IL-18 when compared to controls [31],[45]. In addition, high throughput mRNA profiling in these patients suffering from severe melioidosis furthermore demonstrated increased transcription of a whole array of proinflammatory genes in whole blood leukocytes [26]. In light of the proinflammatory properties attributed to MIF in sepsis, we studied the expression and function of MIF in a well-established mouse model of melioidosis [23],[29],[31]. In line with our patient data and in line with various other murine models of sepsis induced by LPS, E. coli or CLP [4],[16],[46], we observed a strong upregulation of MIF expression in both the lungs and blood of mice inoculated with B. pseudomallei. However, MIF seems to play a less important role in the innate immune response in melioidosis, which is in contrast with previous studies pointing towards a central role of MIF in other forms of infection. With regard to bacterial infection, the role of MIF has been first studied in abdominal sepsis caused by either intraperitoneal injection of E. coli or CLP [9],[16]. In these models, anti-MIF from the same source and administered in the exact same dose protected mice from mortality, reduced TNFalpha concentrations and diminished bacterial growth. Very recently it was shown that polymorphisms associated with higher MIF expression may have a beneficial effect in community-acquired pneumonia [47]. In addition, modulation of MIF may have therapeutic advantages in treating acute lung injury in patients with acute pancreatitis complicated by bacterial infection [48]. The fact that anti-MIF only has a minor impact on the immune response to B. pseudomallei could be related to differences in the primary site of infection and/or differences in the pathogens involved [9],[16]. In this respect it is worthwhile noting that MIF regulates innate immune responses in gram-negative infections through modulation of Toll-like receptor 4 [8]. We obtained recent evidence - counter intuitively for a gram-negative infection - that TLR2 impacts on the immune response of the intact host in vivo, whereas TLR4 does not contribute to protective immunity in melioidosis [23]. As such, the minor role of TLR4 in the innate immune response towards B. pseudomallei could be an explanation for our present findings revealing an equally limited role for MIF in melioidosis. Interestingly, during murine Listeria monocytogenes infection, the elimination of bacteria from the spleen and liver was not affected by anti-MIF antibody although this treatment was able to rescue mice from lethal infection [49].
###end p 64
###begin p 65
###xml 50 65 50 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Calandra2">[16]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Roger3">[33]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Bernhagen2">[50]</xref>
###xml 910 914 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Pollak1">[51]</xref>
###xml 50 65 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 229 236 <span type="species:ncbi:562">E. coli</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 871 876 <span type="species:ncbi:10090">mouse</span>
In reverse experiments we found that treatment of B. pseudomallei infected mice with recombinant MIF caused impairment of the bacterial clearance capability. Earlier studies showed that recombinant MIF increased mortality during E. coli sepsis when co-injected with bacteria in mice [16],[33],[50]. In these investigations the effect of recombinant MIF on bacterial loads was not reported. These findings imply that increased concentrations of MIF can be harmful in the acute host response against invading bacteria. In this respect it is of interest that during the immune suppressed state which occurs in the late phase of the septic response and which is characterized by a reduced capacity of immune cells to produce proinflammatory cytokines such as TNFalpha, it was shown that treatment with recombinant MIF could protect animals from bacterial superinfection in a mouse model of CLP-induced peritonitis [51]. This further highlights the potential diverse nature of MIF function during the course of sepsis.
###end p 65
###begin p 66
###xml 96 111 96 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga2">[23]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga4">[29]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-Wiersinga6">[31]</xref>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000605-vanderPoll1">[52]</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 96 111 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
Our study has several limitations. Our observations were done in patients with sepsis caused by B. pseudomallei and caution is required when extending these findings to less severe or chronic melioidosis, since we focused on the early acute phase of melioidosis. Furthermore, although our in vivo model of melioidosis has been important in elucidating the role of other inflammatory mediators in melioidosis [23],[29],[31], data obtained from a mouse model by definition should be extrapolated to patients with melioidosis with great caution. In addition, it would be of interest to confirm our results in MIF knockout mice, although we consider it less likely that the use of these mice will yield strongly different data in light of the modest differences observed in the different treatment groups. Lastly, obtaining new biological insights from studies using antibodies and recombinant proteins of interest remains a challenge, limited by the notion of considerable cooperation between inflammatory factors involved and extensive redundancy in the host response against invading pathogens [52].
###end p 66
###begin p 67
###xml 425 440 425 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 425 440 <span type="species:ncbi:28450">B. pseudomallei</span>
In conclusion, MIF concentrations are markedly increased during melioidosis, and elevated levels correlate with mortality. Although mice with experimentally induced melioidosis showed strongly upregulated expression of MIF in lungs and blood, inhibition of MIF with a specific antibody only modestly influenced the host response. Similarly, administration of recombinant MIF did not strongly impact on the immune response to B. pseudomallei infection. These data argue against an important role for MIF in the pathogenesis of melioidosis.
###end p 67
###begin p 68
We are grateful to Anneke Geurts, Marieke ten Brink, Joost Daalhuisen en Regina de Beer for expert technical assistance. Prof. J. W. van der Meer is greatly acknowledged for fruitful discussions leading towards the work presented in this study.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.
###end article-title 70
###begin article-title 71
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.
###end article-title 71
###begin article-title 72
Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
###end article-title 72
###begin article-title 73
Macrophage migration inhibitory factor: a regulator of innate immunity.
###end article-title 73
###begin article-title 74
Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
###end article-title 74
###begin article-title 75
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
###end article-title 75
###begin article-title 76
Macrophage migration inhibitory factor.
###end article-title 76
###begin article-title 77
MIF regulates innate immune responses through modulation of Toll-like receptor 4.
###end article-title 77
###begin article-title 78
Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).
###end article-title 78
###begin article-title 79
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.
###end article-title 79
###begin article-title 80
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.
###end article-title 80
###begin article-title 81
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
###end article-title 81
###begin article-title 82
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis.
###end article-title 82
###begin article-title 83
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis.
###end article-title 83
###begin article-title 84
###xml 92 97 <span type="species:ncbi:9606">human</span>
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
###end article-title 84
###begin article-title 85
Protection from septic shock by neutralization of macrophage migration inhibitory factor.
###end article-title 85
###begin article-title 86
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
###end article-title 86
###begin article-title 87
Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.
###end article-title 87
###begin article-title 88
Melioidosis.
###end article-title 88
###begin article-title 89
###xml 48 73 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.
###end article-title 89
###begin article-title 90
Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions.
###end article-title 90
###begin article-title 91
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
###end article-title 91
###begin article-title 92
###xml 76 101 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Toll-Like Receptor 2 Impairs Host Defense in Gram-Negative Sepsis Caused by Burkholderia pseudomallei (Melioidosis).
###end article-title 92
###begin article-title 93
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
###end article-title 93
###begin article-title 94
###xml 114 120 <span type="species:ncbi:9606">humans</span>
Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.
###end article-title 94
###begin article-title 95
###xml 106 131 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei.
###end article-title 95
###begin article-title 96
###xml 21 46 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 102 121 <span type="species:ncbi:13373">Burkholderia mallei</span>
###xml 143 158 <span type="species:ncbi:28450">B. pseudomallei</span>
Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b.
###end article-title 96
###begin article-title 97
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Biodefense-driven murine model of pneumonic melioidosis.
###end article-title 97
###begin article-title 98
Expression Profile and Function of Triggering Receptor Expressed on Myeloid Cells-1 during Melioidosis.
###end article-title 98
###begin article-title 99
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Inflammation patterns induced by different Burkholderia species in mice.
###end article-title 99
###begin article-title 100
Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis.
###end article-title 100
###begin article-title 101
Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis.
###end article-title 101
###begin article-title 102
Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
###end article-title 102
###begin article-title 103
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.
###end article-title 103
###begin article-title 104
An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood.
###end article-title 104
###begin article-title 105
A rapid and simple microfluorometric phagocytosis assay.
###end article-title 105
###begin article-title 106
###xml 65 90 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 94 98 <span type="species:ncbi:10090">Mice</span>
CD14 Impairs Host Defense against Gram-Negative Sepsis Caused by Burkholderia pseudomallei in Mice.
###end article-title 106
###begin article-title 107
Acute lower respiratory tract infection.
###end article-title 107
###begin article-title 108
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients.
###end article-title 108
###begin article-title 109
###xml 63 78 <span type="species:ncbi:11082">West Nile virus</span>
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.
###end article-title 109
###begin article-title 110
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
###end article-title 110
###begin article-title 111
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
###end article-title 111
###begin article-title 112
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
###end article-title 112
###begin article-title 113
###xml 121 129 <span type="species:ncbi:9606">children</span>
###xml 135 156 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
###end article-title 113
###begin article-title 114
Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis).
###end article-title 114
###begin article-title 115
Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation.
###end article-title 115
###begin article-title 116
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.
###end article-title 116
###begin article-title 117
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
###end article-title 117
###begin article-title 118
###xml 61 83 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice.
###end article-title 118
###begin article-title 119
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.
###end article-title 119
###begin article-title 120
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
###end article-title 120
###begin article-title 121
Host-pathogen interactions in sepsis.
###end article-title 121
###begin p 122
The authors have declared that no competing interests exist.
###end p 122
###begin p 123
We acknowledge the support of the Dutch Foundation for Tropical Research (WOTRO), The Netherlands; the Wellcome Trust, England; the Swiss National Science Foundation (310000-118266); the Leenaards Foundation; and the Santos-Suarez Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 123

